In the published article, the reference for () was incorrectly written as “Georgalas, L, Tservakis, I, Kiskira, EE, Petrou, P, Papaconstantinou, D, and Kanakis, M. Efficacy and safety of intravitreal dexamethasone implant in treatment-resistant diabetic macular edema: six-month results. Cesk Slov Oftalmol. (2025) 81:330–7. doi: 10.31348/2025/4.” It should be “Berhuni M, Yılmaz İE, Gizem GS, Özcan ZÖ, Doğan L. Efficacy and safety of intravitreal dexamethasone implant in treatment-resistant diabetic macular edema: six-month results. Cesk Slov Oftalmol. (2025) 81:1–6. doi: 10.31348/2025/4.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
5.
BerhuniMYılmazİEGizemGSÖzcanZÖDoğanL. Efficacy and safety of intravitreal dexamethasone implant in treatment-resistant diabetic macular edema: six-month results. Cesk Slov Oftalmol. (2025) 81:1–6. 10.31348/2025/4
Summary
Keywords
aflibercept biosimilar, diabetic macular edema, foveal avascular zone, vascular density, multifocal electroretinography
Citation
Zhai G, Sun C, Zhang X and Su Y (2025) Corrigendum: Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema. Front. Med. 12:1620932. doi: 10.3389/fmed.2025.1620932
Received
30 April 2025
Accepted
05 May 2025
Published
19 May 2025
Volume
12 - 2025
Edited and reviewed by
Yi Du, The First Affiliated Hospital of Guangxi Medical University, China
Updates
Copyright
© 2025 Zhai, Sun, Zhang and Su.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yuanzhen Su yuanzhenhaoren@126.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.